The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The Late Domain of Human Immunodeficiency Virus Type 1 p6 Promotes Virus Release in a Cell Type-Dependent Manner
Open accessAbstract
The p6 domain of human immunodeficiency virus type 1 (HIV-1) is located at the C terminus of the Gag precursor protein Pr55 Gag . Previous studies indicated that p6 plays a critical role in HIV-1 particle budding from virus-expressing HeLa cells. In this study, we performed a detailed mutational analysis of the N terminus of p6 to map the sequences required for efficient virus release. We observed that the highly conserved P-T/S-A-P motif located near the N terminus of p6 is remarkably sensitive to change; even conservative mutations in this sequence imposed profound virus release defects in HeLa cells. In contrast, single and double amino acid substitutions outside the P-T/S-A-P motif had no significant effect on particle release. The introduction of stop codons one or two residues beyond the P-T/S-A-P motif markedly impaired virion release, whereas truncation four residues beyond P-T/S-A-P had no effect on particle production in HeLa cells. By examining the effects of p6 mutation in biological and biochemical analyses and by electron microscopy, we defined the role of p6 in particle release and virus replication in a panel of T-cell and adherent cell lines and in primary lymphocytes and monocyte-derived macrophages. We demonstrated that the effects of p6 mutation on virus replication are markedly cell type dependent. Intriguingly, even in T-cell lines and primary lymphocytes in which p6 mutations block virus replication, these changes had little or no effect on particle release. However, p6-mutant particles produced in T-cell lines and primary lymphocytes exhibited a defect in virion-virion detachment, resulting in the production of tethered chains of virions. Virus release in monocyte-derived macrophages was markedly inhibited by p6 mutation. To examine further the cell type-specific virus release defect in HeLa versus T cells, transient heterokaryons were produced between HeLa cells and the Jurkat T-cell line. These heterokaryons display a T-cell-like phenotype with respect to the requirement for p6 in particle release. The results described here define the role of p6 in virus replication in a wide range of cell types and reveal a strong cell type-dependent requirement for p6 in virus particle budding.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutational analysis of HIV-1 p6 has been instrumental in identifying a short Pro-Thr/Ser-Ala-Pro (PT/SAP) motif, which is critical for particle release”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Demirov et al. 2002
Citations
Cites
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,309
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T. M., Willey, R. L., Rabson, A. B., & Martín, M. Á. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,805
Interaction of Tyrosine-Based Sorting Signals with Clathrin-Associated Proteins
Ohno, H., Stewart, J., Fournier, M.-C., Bosshart, H., Rhee, I. P., Miyatake, S., Saito, T., Gallusser, A., Kirchhausen, T. L., & Bonifacino, J. S. (1995) · Science · doi:10.1126/science.7569928 · Cited by 971
SH2 and SH3 domains: From structure to function
Pawson, T. J., & Gish, G. D. (1992) · Cell · doi:10.1016/0092-8674(92)90504-6 · Cited by 940
Signal-Dependent Membrane Protein Trafficking in the Endocytic Pathway
Trowbridge, I. S., Collawn, J. F., & Hopkins, C. R. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001021 · Cited by 811
HIV-1 Gag proteins: diverse functions in the virus life cycle
Freed, E. O. (1998) · Virology · doi:10.1006/viro.1998.9398 · Cited by 717
Self-citationEffect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release
Göttlinger, H. G., Dorfman, T., Sodroski, J. G., & Haseltine, W. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3195 · Cited by 647
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag
VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J., & Carter, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131059198 · Cited by 584
Synthesis, Assembly, and Processing of Viral Proteins
Swanstrom, R. I., & Wills, J. (1997) · Europe PMC (PubMed Central) · Cited by 518
Huang, M., Orenstein, J. M., Martin, M. A., & Freed, E. O. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6810-6818.1995 · Cited by 486
Self-citation
Research works printed but not linked: 1
- Freed, E. O., and M. A. Martin. 2001. HIVs and their replication, p. 1971–2041. In D. M. Knipe and P. M. Howley (ed.). Fields virology, 4th ed. Lippincott, Philadelphia, Pa.
Cited by
Sorted by citations
Items 101–200 of 201
Effects of Gag Mutation and Processing on Retroviral Dimeric RNA Maturation
Fu, W., Dang, Q., Nagashima, K., Freed, E. O., Pathak, V. K., & Hu, W.-S. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1242-1249.2006 · Cited by 27
Self-citationHui, K.-W. E., Barman, S., Yang, T.-Y., Tang, H.-P., France, B., & Nayak, D. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2291-2308.2006 · Cited by 28
RetractedThe Role of Caveolin 1 in HIV Infection and Pathogenesis
Mergia, A. (2017) · Viruses · doi:10.3390/v9060129 · Cited by 29
Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release
Votteler, J., Iavnilovitch, E., Fingrut, O., Shemesh, V., Taglicht, D., Erez, O., Sörgel, S., Walther, T., Bannert, N., Schubert, U., et al. (2009) · BMC Biochemistry · doi:10.1186/1471-2091-10-12 · Cited by 27
The NC domain of HIV-1 Gag contributes to the interaction of Gag with TSG101
El Meshri, S. E., Boutant, E., Mouhand, A., Thomas, A., Larue, V., Richert, L., Vivet-Boudou, V., Mély, Y., Tisné, C., Muriaux, D., et al. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.03.020 · Cited by 25
Analysis of HIV-1 CRF07_BC gag p6 sequences indicating novel deletions in the central region of p6
Song, Y., Meng, Z., Xing, H. Q., Ruan, Y., Li, X. P., Xin, R., F., P., Peng, H., & Shao, Y. (2007) · Archives of Virology · doi:10.1007/s00705-007-0973-6 · Cited by 25
Smirnova, E., Collingwood, T., Bisbal, C., Tsygankova, O., Bogush, M., Meinkoth, J., Henderson, E., Annan, R., & Tsygankov, A. (2008) · Virology · doi:10.1016/j.virol.2007.10.012 · Cited by 26
Role of the Human T-Cell Leukemia Virus Type 1 PTAP Motif in Gag Targeting and Particle Release
Dorweiler, I. J., Ruone, S. J., Wang, H., Burry, R. W., & Mansky, L. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3634-3643.2006 · Cited by 25
HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
Tedbury, P. R., & Freed, E. O. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_436 · Cited by 27
Self-citationIrie, T., & Harty, R. N. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12617-12622.2005 · Cited by 24
Duchon, A. A., Santos, S., Chen, J., Brown, M., Nikolaitchik, O. A., Tai, S., Chao, J. A., Freed, E. O., Pathak, V. K., & Hu, W.-S. (2021) · mBio · doi:10.1128/mbio.03254-21 · Cited by 23
Self-citationObiang, L., Raux, H., Ouldali, M., Blondel, D., & Gaudin, Y. (2011) · Journal of General Virology · doi:10.1099/vir.0.039800-0 · Cited by 22
ESCRT Machinery Potentiates HIV-1 Utilization of the PI(4,5)P2-PLC-IP3R-Ca2+ Signaling Cascade
Ehrlich, L. S., Medina, G. N., & Carter, C. A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.08.038 · Cited by 21
Ott, D. E., Coren, L. V., Gagliardi, T. D., & Nagashima, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9038-9045.2005 · Cited by 21
Structural basis for endosomal recruitment of ESCRT‐I by ESCRT‐0 in yeast
Ren, X., & Hurley, J. H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.122 · Cited by 25
Salgado, G. F. J., Vogel, A., Marquant, R., Feller, S. E., Bouaziz, S., & Alves, I. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901106t · Cited by 21
Impact of Insertions in the HIV-1 P6 Ptapp Region on the Virological Response to Amprenavir
the NARVAL Trial Group (ANRS 088), Lastère, S., Dalban, C., Collin, G., Descamps, D., Girard, P., Clavel, F., Costagliola, D. G., Brun‐Vézinet, F., Brun‐Vézinet, F., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900215 · Cited by 21
Glutamic Acid Residues in HIV-1 p6 Regulate Virus Budding and Membrane Association of Gag
Friedrich, M., Setz, C., Hahn, F., Matthaei, A., Fraedrich, K., Rauch, P., Henklein, P., Traxdorf, M., Fossen, T., & Schubert, U. (2016) · Viruses · doi:10.3390/v8040117 · Cited by 27
Albright, A. V., Vos, R. M., & González‐Scarano, F. (2004) · Virology · doi:10.1016/j.virol.2004.04.028 · Cited by 19
Refined study of the interaction between HIV-1 p6 late domain and ALIX
Lazert, C., Chazal, N., Briant, L., Gerlier, D., & Cortay, J. (2008) · Retrovirology · doi:10.1186/1742-4690-5-39 · Cited by 18
Reed, J. C., Westergreen, N., Barajas, B. C., Ressler, D. T. B., Phuong, D. J., Swain, J. V., Lingappa, V. R., & Lingappa, J. R. (2018) · Journal of Virology · doi:10.1128/jvi.01761-17 · Cited by 18
HIV Pol Inhibits HIV Budding and Mediates the Severe Budding Defect of Gag-Pol
Gan, X., & Gould, S. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029421 · Cited by 17
Kawada, S., Goto, T., Haraguchi, H., Ono, A., & Morikawa, Y. (2008) · Journal of Virology · doi:10.1128/jvi.01953-07 · Cited by 18
van Domselaar, R., Njenda, D. T., Rao, R. K., Sönnerborg, A. B., Singh, K., & Neogi, U. (2019) · Journal of Virology · doi:10.1128/jvi.00077-19 · Cited by 16
Brumme, Z., Chan, K., Dong, W., Wynhoven, B., Mo, T., Hogg, R., Montaner, J., O'Shaughnessy, M., & Harrigan, P. (2002) · Antiviral Therapy · doi:10.1177/135965350300800202 · Cited by 17
Molecular characterization of the HIV-1 gagnucleocapsid gene associated with vertical transmission
Wellensiek, B. P., Sundaravaradan, V., Ramakrishnan, R., & Ahmad, N. (2006) · Retrovirology · doi:10.1186/1742-4690-3-21 · Cited by 17
HIV-1 p6—Another viral interaction partner to the host cellular protein cyclophilin A
Solbak, S. M. Ø., Reksten, T. R., Röder, R., Wray, V., Horvli, O., Raae, A. J., Henklein, P., Henklein, P., & Fossen, T. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.02.002 · Cited by 16
The Role of ITCH Protein in Human T-cell Leukemia Virus Type 1 Release
Dorjbal, B., Derse, D., Lloyd, P. A., Soheilian, F., Nagashima, K., & Heidecker, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.259945 · Cited by 16
HIV-1 budding requires cortical actin disassembly by the oxidoreductase MICAL1
Serrano, T., Casartelli, N., Ghasemi, F., Wioland, H., Cuvelier, F., Salles, A., Moya‐Nilges, M., Welker, L., Bernacchi, S., Ruff, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2407835121 · Cited by 16
Rose, K. M., Spada, S. J., Hirsch, V. M., & Bouamr, F. (2021) · Viruses · doi:10.3390/v13061138 · Cited by 16
Defects in cellular sorting and retroviral assembly induced by GGA overexpression
Joshi, A., Nagashima, K., & Freed, E. O. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-72 · Cited by 15
Self-citationHill, M. K., Bellamy-McIntyre, A. K., Vella, L. J., Campbell, S. M., Marshall, J., Tachedjian, G., & Mak, J. (2006) · Current HIV Research · doi:10.2174/157016207779316323 · Cited by 21
Marcucci, K. T., Martina, Y., Harrison, F., Wilson, C. A., & Salomon, D. R. (2008) · Virology · doi:10.1016/j.virol.2008.02.017 · Cited by 15
Hahn, F., Setz, C., Friedrich, M., Rauch, P., Solbak, S. M. Ø., Frøystein, N. Å., Henklein, P., Votteler, J., Fossen, T., & Schubert, U. (2014) · Viruses · doi:10.3390/v6103738 · Cited by 14
Identification of late assembly domains of the human endogenous retrovirus-K(HML-2)
Chudak, C., Beimforde, N., George, M., Zimmermann, A., Lausch, V., Hanke, K., & Bannert, N. (2013) · Retrovirology · doi:10.1186/1742-4690-10-140 · Cited by 15
Ubiquitin Ligase SMURF2 Interacts with Filovirus VP40 and Promotes Egress of VP40 VLPs
Shepley‐McTaggart, A., Schwoerer, M. P., Sagum, C. A., Bedford, M. T., Jaladanki, C. K., Fan, H., Cassel, J. A., & Harty, R. N. (2021) · Viruses · doi:10.3390/v13020288 · Cited by 14
Analysis of the retrovirus capsid interdomain linker region
Arvidson, B., Seeds, J. D., Webb, M., Finlay, L. A., & Barklis, E. (2003) · Virology · doi:10.1016/s0042-6822(02)00142-3 · Cited by 14
Bleiber, G., Peters, S., Martínez, R., Cmarko, D., Meylan, P., & Telenti, A. (2004) · Journal of General Virology · doi:10.1099/vir.0.19576-0 · Cited by 16
Aiamkitsumrit, B., Sullivan, N. T., Nonnemacher, M. R., Pirrone, V., & Wigdahl, B. L. (2015) · Advances in virus research · doi:10.1016/bs.aivir.2015.04.001 · Cited by 14
Hydrogen Bonding at a Conserved Threonine in Lentivirus Capsid Is Required for Virus Replication
Rue, S. M., Roos, J. W., Amzel, L. M., Clements, J. E., & Barber, S. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.8009-8018.2003 · Cited by 14
Conformational transitions of the HIV-1 Gag polyprotein upon multimerization and gRNA binding
Banerjee, P., & Voth, G. A. (2023) · Biophysical Journal · doi:10.1016/j.bpj.2023.11.017 · Cited by 15
Identification of conserved motifs in the Westnile virus envelope essential for particle secretion
Garg, H., Lee, R. T., Tek, N. O., Maurer‐Stroh, S., & Joshi, A. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-197 · Cited by 13
Variability in the P6gag domains of HIV-1 involved in viral budding
Holguín, Á., Álvarez, A., & Soriano, V. (2006) · AIDS · doi:10.1097/01.aids.0000210619.75707.21 · Cited by 13
Peptide Inhibitors of HIV-1 Egress
Waheed, A. A., & Freed, E. O. (2008) · ACS Chemical Biology · doi:10.1021/cb800296j · Cited by 13
Self-citationSiarot, L., Chutiwitoonchai, N., Sato, H., Chang, H., Sato, H., Fujino, M., Murakami, T., Aono, T., Kodama, E. N., Kuroda, K., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.079 · Cited by 12
Benner, B. E., Bruce, J. W., Kentala, J. R., Murray, M. B., Becker, J. T., Garcia-Miranda, P., Ahlquist, P., Butcher, S. E., & Sherer, N. M. (2021) · Journal of Virology · doi:10.1128/jvi.01349-21 · Cited by 14
Tsg101 regulates PI(4,5)P2/Ca2+ signaling for HIV-1 Gag assembly
Ehrlich, L. S., Medina, G. N., Photiadis, S. J., Whittredge, P. B., Watanabe, S. M., Taraska, J. W., & Carter, C. A. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00234 · Cited by 12
Wanaguru, M., & Bishop, K. N. (2021) · Journal of Virology · doi:10.1128/jvi.00554-21 · Cited by 14
Joshi, A., & Freed, E. O. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.427 · Cited by 11
Self-citationInhibition of Human Immunodeficiency Virus Type 1 by Triciribine Involves the Accessory Protein Nef
Ptak, R. G., Gentry, B. G., Hartman, T. L., Watson, K. M., Osterling, M. C., Buckheit, R. W., Townsend, L. B., & Drach, J. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-09 · Cited by 10
Norgan, A. P., Lee, J. R. E., Oestreich, A. J., Payne, J. A., Krueger, E., & Katzmann, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052603 · Cited by 8
Kimura, S., Maeda, K., Nagashima, R., Miura, K., Arakawa, M., Ebina, H., Tanaka, N., & Morita, E. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.04.021 · Cited by 8
Deletions in the fifth alpha helix of HIV-1 matrix block virus release
Sanford, B. L., Li, Y., Maly, C. J., Madson, C. J., Chen, H., Zhou, Y., & Belshan, M. (2014) · Virology · doi:10.1016/j.virol.2014.08.017 · Cited by 8
Adamson, C. S., Davies, A., Soneoka, Y., Nermut, M., Mitrophanous, K., & Jones, I. (2003) · Virology · doi:10.1016/s0042-6822(03)00485-9 · Cited by 7
Ojesina, A., Chaplin, B., Sankalé, J., Murphy, R., Idigbe, E., Adewole, I., Ekong, E., Idoko, J., & Kanki, P. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0308 · Cited by 9
A PLPPV sequence in the p8 region of Gag provides late domain function for mouse mammary tumor virus
Coren, L. V., Nagashima, K., & Ott, D. E. (2019) · Virology · doi:10.1016/j.virol.2019.07.015 · Cited by 6
Benner, B. E., Bruce, J. W., Kentala, J. R., Murray, M. B., Becker, J. T., García‐Miranda, P., Ahlquist, P., Butcher, S. E., & Sherer, N. M. (2022) · idUS (Universidad de Sevilla) · Cited by 6
Costa, M. J. L., Pedro, L., Matos, A., Aires-Barros, M. R., Belo, J. A., Gonçalves, J., & Ferreira, G. N. M. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060208 · Cited by 6
Ubiquitin ligases as therapeutic targets in HIV-1 infection
Votteler, J., & Schubert, U. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.2.131 · Cited by 6
Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication
Jehad, M. A., Ali, L. M., Pillai, V. N., Prabhu, S. G., Mustafa, F., & Rizvi, T. A. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf066 · Cited by 5
“11 ) (Garrus et al. 2001 , Martin-Serrano et al. 2001 , VerPlank et al. 2001 , Demirov et al. 2002 , Strack et al. 2003 , Fisher et al. 2007 , Lee et al. 2007 , Mun-shi et al. 2007 , Zhai et al. 2008 , Dussupt et al. 2009 , Friedrich et al. 2016 , Schemelev et al. 2024 ).”
Anang, S., Zhang, S., Ennis, A., Ding, H., Deshpande, A. A., Nguyen, H. T., Kappes, J. C., & Sodroski, J. (2025) · Journal of Virology · doi:10.1128/jvi.01585-25 · Cited by 5
Nikolaitchik, O. A., Gorelick, R. J., Leavitt, M. G., Pathak, V. K., & Hu, W.-S. (2008) · Virology · doi:10.1016/j.virol.2008.02.026 · Cited by 5
The N-Terminus of the HIV-1 p6 Gag Protein Regulates Susceptibility to Degradation by IDE
Schmalen, A., Karius-Fischer, J., Rauch, P., Setz, C., Korn, K., Henklein, P., Fossen, T., & Schubert, U. (2018) · Viruses · doi:10.3390/v10120710 · Cited by 5
Gag-p6 Tsg101 Binding Site Duplications in Maternal–Infant HIV Infection
Colgrove, R. C., Millet, A., Bauer, G. R., Pitt, J., & Welles, S. L. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.191 · Cited by 5
Pikora, C., Wittish, C., & Desrosiers, R. C. (2005) · Virology · doi:10.1016/j.virol.2005.10.040 · Cited by 5
Schubert, U., & McClure, M. O. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0266 · Cited by 4
Computational Studies of HIV-1 Protease Inhibitors
Schaal, W. (2002) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 4
EAP45 association with budding HIV ‐1: Kinetics and domain requirements
Meng, B., Ramirez, P. P. V., Scherer, K. M., Bruggeman, E., Kenyon, J. C., Kaminski, C. F., & Lever, A. M. L. (2021) · Traffic · doi:10.1111/tra.12820 · Cited by 3
Evolutionary conservation of an ancient retroviral gagpol gene in Artiodactyla
Simpson, J., Kozak, C. A., & Boso, G. (2023) · Journal of Virology · doi:10.1128/jvi.00535-23 · Cited by 5
Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals
Montero, F., Parra‐López, M., Martínez, A. R., Murciano‐Calles, J., Buzón, P., Han, Z., Lin, L., Ramos, M. C., Ruiz‐Sanz, J., Martínez, J. C., et al. (2024) · Protein Science · doi:10.1002/pro.70005 · Cited by 2
Fluorescence lifetime imaging applied to multiwell plate FRET assays for high content analysis
Alibhai, D. (2013) · doi:10.25560/40284 · Cited by 1
Carter, C. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811185-7.00009-1 · Cited by 2
The Roles of ESCRT Proteins in Healthy Cells and in Disease
Ilievska, J., Naomi, E., Sarah, J. M., & Paul, R. (2012) · InTech eBooks · doi:10.5772/33537 · Cited by 2
Preece, B., Peppel, W., Gallegos, R., Ysassi, G., Clinger, G., Bohn, N., Adhikary, B., Mendonça, L., Belnap, D. M., Vershinin, M. D., et al. (2025) · Viruses · doi:10.3390/v17030364 · Cited by 1
Göttlinger, H. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7729-7_5 · Cited by 1
Development of a 293T Cell Line for the Production of Virus Like Particles in Bioreactors
Costa, M. J., Malhó, R., Gonçalves, J., Ferreia, G. N. M., & Aires-Barros, M. R. (2005) · Springer eBooks · doi:10.1007/1-4020-3103-3_64 · Cited by 1
Conserved serines in simian immunodeficiency virus capsid are required for virus budding
Rue, S. M., Roos, J. W., Clements, J. E., & Barber, S. A. (2005) · Virology · doi:10.1016/j.virol.2005.03.006 · Cited by 1
Wellensiek, B. P. (2007) · UA Campus Repository (The University of Arizona) · Cited by 1
Co-evolution of HIV-1 Protease and its Substrates: A Dissertation
Kolli, M. (2009) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/hnsw-f822
Studies of Fv1 binding and restriction
Li, H. L. W. (2015) · UCL Discovery (University College London)
Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release
Votteler, J., Iavnilovitch, E., Fingrut, O., Shemesh, V., Taglicht, D., Erez, O., Sörgel, S., Walther, T., Bannert, N., Schubert, U., et al. (2009) · Retrovirology · doi:10.1186/1742-4690-6-s2-p92 · Cited by 1
Compounds Derived from Birch Trees that Inhibit HIV-1 Replication
Dorr, C. R. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
HIV-1 NEF: THERAPEUTIC STRATEGIES AND VIROLOGICAL SYNAPSE-MEDIATED INFECTION
Green, L. A. (2011) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1705
HIV-1 NEF: THERAPEUTIC STRATEGIES AND VIROLOGICAL
Green, L. A. (2010)
Sen, S., Tripathy, S. P., & Paranjape, R. (2017) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2017.605.143
Kiguoya, M. W. (2016) · ResearchSpace (University of KwaZulu-Natal)
Martin, G. E. (2007) · Corpus Université Laval (Université Laval)
Norgan, A. P., Lee, J. R. E., Oestreich, A. J., Payne, J. A., Krueger, E., & Katzmann, D. J. (2013) · PLoS ONE · doi:10.1371/annotation/bb8f73cc-4355-4198-b020-e9cdfb6ced86
Distinct domain requirements for EAP45 in HIV budding, late endosomal recruitment, and cytokinesisPreprint
Meng, B., Ramirez, P. P. V., Scherer, K. M., Bruggeman, E., Kenyon, J. C., Kaminski, C. F., & Lever, A. M. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.23.112607
Defining interactions between assembling HIV-1 virions and host cell plasma membrane proteins
Grover, J. R. (2013) · Deep Blue (University of Michigan)
Preece, B., Peppel, W., Gallegos, R., Yassasi, G., Clinger, G., Bohn, N., Adhikary, B., Mendonça, L., Belnap, D. M., Vershinin, M. D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.12.628087
Etude des mécanismes contrôlant la spécificité d'encapsidation des ARN dans le VIH-1
Didierlaurent, L. (2010) · theses.fr (ABES) · doi:10.70675/6af45cb6z95b9z414cz94fbzdcd9c17fde4a
Giroud, C. (2012) · theses.fr (ABES) · doi:10.70675/dcb13f1azfc90z47d6zb978z456e9b4d70d5
The intracellular trafficking of HIV-1 Gag protein and the role of its NCp7 domain
Meshri, S. E. E. (2015) · theses.fr (ABES) · doi:10.70675/e50e7319z2bebz46d8z8039zf29efb7c4e4b
HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies
Georgiev, V. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-297-1_34
Metadata
- Authors
- Demirov, D. G., Orenstein, J. M., & Freed, E. O.
- Affiliations
- National Institutes of Health (US)
- George Washington University (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2002-01
- Volume
- 76
- Issue
- 1
- Pages
- 105-117
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC135729
- OpenAlex
- W2056548409
- Cited by
- 201
- References
- 67
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 8 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 9 · 2014: 6 · 2013: 9 · 2012: 10
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- Pr55gag, viral budding, particle release, cell type dependence, viral replication, monocyte-derived macrophages, T cell lines, heterokaryons, HeLa cells, primary lymphocytes
- MeSH terms
- Amino Acid Sequence, Cells, Cultured, Eukaryotic Cells, HeLa Cells, Humans, Lymphocytes, Macrophages, Molecular Sequence Data, Virus Replication, HIV-1, Gene Products, gag, Mutagenesis, Site-Directed, Codon, Terminator, Jurkat Cells, gag Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review